Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.
Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.
Susan Sieber, Former NCI Communications Chief, Dead.
Andrew von Eschenbach Sworn In As NCI Director.
Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.
Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.
FDA Approves Abbott’s HER-2 DNA Probe Kit.
Univ. Of Pittsburgh Plans Molecular Medicine Institute.
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- CBER Director Vinay Prasad dared to “say no to drugs”









